Terms: = Prostate cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Treatment
10 results:
1. The Role of Theragnostics in Breast cancer: A Systematic Review of the Last 12 Years.
Balma M; Liberini V; Buschiazzo A; Racca M; Rizzo A; Nicolotti DG; Laudicella R; Quartuccio N; Longo M; Perlo G; Terreno E; Abgral R; William Huellner M; Papaleo A; Deandreis D
Curr Med Imaging; 2023; 19(8):817-831. PubMed ID: 36797602
[TBL] [Abstract] [Full Text] [Related]
2. Comparing current and emerging practice models for the extrapolation of survival data: a simulation study and case-study.
Kearns B; Stevenson MD; Triantafyllopoulos K; Manca A
BMC Med Res Methodol; 2021 Nov; 21(1):263. PubMed ID: 34837957
[TBL] [Abstract] [Full Text] [Related]
3. Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT prostate multivariable model.
Thurtle DR; Greenberg DC; Lee LS; Huang HH; Pharoah PD; Gnanapragasam VJ
PLoS Med; 2019 Mar; 16(3):e1002758. PubMed ID: 30860997
[TBL] [Abstract] [Full Text] [Related]
4. Androgen and Estrogen Receptor Imaging in Metastatic Breast cancer Patients as a Surrogate for Tissue Biopsies.
Venema CM; Mammatas LH; Schröder CP; van Kruchten M; Apollonio G; Glaudemans AWJM; Bongaerts AHH; Hoekstra OS; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Boellaard R; Menke van der Houven van Oordt CW; Hospers GAP
J Nucl Med; 2017 Dec; 58(12):1906-1912. PubMed ID: 28912144
[TBL] [Abstract] [Full Text] [Related]
5. Personalized & Precision Medicine in cancer: A Theranostic Approach.
Choudhury P; Gupta M
Curr Radiopharm; 2017 Nov; 10(3):166-170. PubMed ID: 28758574
[TBL] [Abstract] [Full Text] [Related]
6. A mathematical theory of shape and neuro-fuzzy methodology-based diagnostic analysis: a comparative study on early detection and treatment planning of brain cancer.
Kar S; Majumder DD
Int J Clin Oncol; 2017 Aug; 22(4):667-681. PubMed ID: 28321787
[TBL] [Abstract] [Full Text] [Related]
7. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract] [Full Text] [Related]
8. Hot topics in urological health economics. A mini review.
Racioppi M; Palermo G; D'Addessi A; Pinto F; Sacco E; D'Agostino D; Vittori M; Bassi PF
Arch Ital Urol Androl; 2012 Jun; 84(2):47-52. PubMed ID: 22908771
[TBL] [Abstract] [Full Text] [Related]
9. Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer.
Denham JW; Kumar M; Gleeson PS; Lamb DS; Joseph D; Atkinson C; Matthews J; Tai KH; Spry NA; Christie D; Turner S; Greer PB; D'Este C; Steigler A
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):404-11. PubMed ID: 19176272
[TBL] [Abstract] [Full Text] [Related]
10. Semiautomatic nonrigid registration for the prostate and pelvic MR volumes.
Fei B; Duerk JL; Sodee DB; Wilson DL
Acad Radiol; 2005 Jul; 12(7):815-24. PubMed ID: 16039535
[TBL] [Abstract] [Full Text] [Related]
